A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult Volunteers

NCT04223895 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Type2 Diabetes Mellitus

Interventions

DRUG: CKD-386 Formulation 1
DRUG: CKD-386 Formulation 2
DRUG: D012, D326 and D337

Sponsor

Chong Kun Dang Pharmaceutical